NCT05672485View on ClinicalTrials.gov

99mTc-P137 SPECT/CT in Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

SPECT/CT imaging with 99mTc-P137 nuclide probe

inject the tracer 99mTc-P137 to subjects and perform SPECT/CT scans

Trial Locations (1)

710061

RECRUITING

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER